CompletedNot Applicable

Eisenmenger Quality Enhancement Research Initiative

193 participantsStarted 2012-07-01

Plain-language summary

Eisenmenger Quality Enhancement Research Initiative (QuERI) is a multi-center, observational, US-based longitudinal program, with enrollment of consecutive Eisenmenger patients who meet enrollment. Patient data will be collected prospectively for three years. Individual physician feedback will be provided on data collected with the purpose of improving the management of patients - quality enhancement research initiative (QuERI) process.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and female patients * Diagnosis of Eisenmenger syndrome based on right heart catheterization data * Right to Left intra-cardiac shunting * PAH * Need for comprehensive management according to guidelines and peer-reviewed evidence * Ability and desire to execute the consent for follow up Exclusion Criteria: * Poor mental function, drug, or substance (e.g.,alcohol) abuse, or unstable psychiatric illness, which, in the opinion of the investigator, may interfere with optimal participation in the study * Prior inclusion in this program

What they're measuring

Characterization of the clinical course of patients with Eisenmenger Syndrome

Timeframe: up to 3 years

Trial details

NCT IDNCT01623492

SponsorActelion

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2018-04-17

View on ClinicalTrials.gov More Pulmonary Arterial Hypertension trials